IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$366M
AUM Growth
+$96.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1
+$32.6M
2
+$16.3M
3
+$13.4M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$12.7M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$6.77M

Top Sells

1
+$10.1M
2
+$9.16M
3
+$7.92M
4
PCVX icon
Vaxcyte
PCVX
+$7.26M
5
GPCR icon
Structure Therapeutics
GPCR
+$7.07M

Sector Composition

1 Healthcare 92.55%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$4.42M 1.21%
70,546
+40,000
27
$3.8M 1.04%
+285,900
28
$3.79M 1.04%
346,471
29
$3.01M 0.82%
+600,000
30
$2.95M 0.81%
+270,000
31
$2.88M 0.79%
374,807
32
$2.74M 0.75%
602,868
-80,000
33
$2.67M 0.73%
90,162
-300,000
34
$2.58M 0.71%
305,857
35
$2.5M 0.69%
+30,000
36
$2.44M 0.67%
+24,546
37
$2.2M 0.6%
+600,000
38
$2.06M 0.56%
+34,361
39
$1.86M 0.51%
3,583
40
$1.85M 0.51%
1,222,852
41
$1.7M 0.47%
151,821
+150,000
42
$1.69M 0.46%
262,694
43
$1.56M 0.43%
555,572
44
$1.26M 0.34%
412,881
+100,000
45
$1.21M 0.33%
315,265
46
$1.18M 0.32%
195,899
47
$1.13M 0.31%
340,787
-525,000
48
$1.12M 0.31%
688,604
49
$1.07M 0.29%
165,480
50
$1.07M 0.29%
157,365
1
2
3 4 5